EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

An Overview of the Epidemiology of Multidrug Resistance and Bacterial Resistance Mechanisms: What Solutions Are Available? A Comprehensive Review

Victoria Birlutiu iD, Rares-Mircea Birlutiu iD

Microorganisms · 19.09.2025 · 13 (9) · 2194

DOI: 10.3390/microorganisms13092194 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 19.09.2025. Verfasst von Victoria Birlutiu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Lucian Blaga University of Sibiu, 550169 Sibiu, Romania. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance has emerged as one of the most critical public health challenges of the 21st century, threatening to undermine the foundations of modern medicine. In 2019, bacterial infections accounted for 13.6% of all global deaths, with more than 7.7 million fatalities directly attributable to 33 bacterial pathogens, most prominently Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Resistance mechanisms are multifactorial, encompassing enzymatic degradation, target modification, efflux pump overexpression, reduced membrane permeability, and biofilm formation, often in combination, leading to multidrug-resistant, extensively drug-resistant, and pandrug-resistant phenotypes. Alarmingly, projections estimate that by 2050 AMR could result in over 10 million deaths annually. This comprehensive review synthesizes global epidemiological data, insights into bacterial resistance mechanisms, and emerging therapeutic solutions, including novel antibiotics such as lasso peptides and macrocyclic peptides (e.g., zosurabalpin), naturally derived compounds (e.g., corallopyronin, clovibactin, chlorotonil A), and targeted inhibitors (e.g., Debio 1453 for Neisseria gonorrhoeae). Addressing the AMR crisis requires coordinated international efforts, accelerated drug discovery, and the integration of innovative non-antibiotic approaches to preserve the efficacy of existing therapies and ensure preparedness against future bacterial threats.

Schlagwörter

Stichwörter der Autor:innen

antimicrobial resistancebacterial resistance mechanismsextensively drug-resistant pathogensglobal epidemiologymultidrug-resistant bacterianovel antibioticspandrug resistance

Autor:innen und Institutionen

  • Faculty of Medicine, Lucian Blaga University of Sibiu, 550169 Sibiu, Romania.
  • County Clinical Emergency Hospital, 550245 Sibiu, Romania.
  • Department 14-Orthopedics, Anaesthesia Intensive Care Unit, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
  • Foisor Clinical Hospital of Orthopedics, Traumatology, and Osteoarticular TB, 030167 Bucharest, Romania.

ORCID-Profile: Victoria Birlutiu, Rares-Mircea Birlutiu

Zitieren

APA

Birlutiu, V., & Birlutiu, R. M. (2025). An Overview of the Epidemiology of Multidrug Resistance and Bacterial Resistance Mechanisms: What Solutions Are Available? A Comprehensive Review. Microorganisms, 13(9), 2194. https://doi.org/10.3390/microorganisms13092194

Vancouver

Birlutiu V, Birlutiu RM. An Overview of the Epidemiology of Multidrug Resistance and Bacterial Resistance Mechanisms: What Solutions Are Available? A Comprehensive Review. Microorganisms. 2025;13(9):2194. doi:10.3390/microorganisms13092194

BibTeX
@article{Birlutiu2025,
  author = {Birlutiu, Victoria and Birlutiu, Rares-Mircea},
  title = {An Overview of the Epidemiology of Multidrug Resistance and Bacterial Resistance Mechanisms: What Solutions Are Available? A Comprehensive Review},
  journal = {Microorganisms},
  year = {2025},
  volume = {13},
  number = {9},
  pages = {2194},
  doi = {10.3390/microorganisms13092194}
}
Kostenlos starten →